Genetic Screening and Assisted Oocyte Activation in Couples with Diminished/aberrant Embryonic Development.

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

September 9, 2022

Conditions
EmbryoEmbryo DisorderGenetic Disease
Interventions
PROCEDURE

AOA

100% ICSI-AOA will be performed.

DIAGNOSTIC_TEST

Genetic screening

Patients will donate a saliva sample. Genetic screening will take place for PLCzeta (male) and Dux4 (male and female). Also other possible genes involved in embryo development could be tested.

DIAGNOSTIC_TEST

Calcium pattern analysis

Male patients will donate a sperm sample. Calcium pattern analysis will take place by injecting the patients' sperm into mouse and/or human (in vitro matured) oocytes (research-donated control oocytes). This will estimate the sperm capability to induce calcium oscillations in the oocyte.

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03354013 - Genetic Screening and Assisted Oocyte Activation in Couples with Diminished/aberrant Embryonic Development. | Biotech Hunter | Biotech Hunter